Indications
Adults Winlevi is indicated for the treatment of acne vulgaris. Adolescents (from 12 to < 18 years of age) Winlevi is indicated for the treatment of facial acne vulgaris.
Composition
- Active substance
- clascoterone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Winlevi
- Active substance
- clascoterone
- ATC code
- D10AX06
- Group
- Dermatologicals
- Therapeutic area
- Acne Vulgaris
- Marketing authorisation holder
- Cassiopea S.p.A.
- Status
- Authorised
- EU authorisation
- 17 Oct 2025